Dr. Ibrahim Alali

I am a seasoned endocrinologist with nearly a decade of clinical experience across Syria, Oman, and the United Arab Emirates. My medical training began at Aleppo University (2006–2012), followed by a comprehensive endocrinology residency at Damascus University (2013–2018). I earned the Syrian Board in Endocrinology in 2018 and completed an MSc in Endocrinology and Diabetes, with a thesis focused on the diagnostic value of fine‑needle aspiration in thyroid malignancy. I also hold the MRCP (UK) and the Specialty Certificate Examination (SCE) in Endocrinology, further strengthening my clinical and academic foundation. My clinical career spans leading private hospitals in Damascus and the Omani Ministry of Health (2023–Dec 2025). Since 2026, I have been practicing with SEHA, where I manage a broad spectrum of endocrine disorders. My areas of expertise include diabetes management, thyroid and pituitary tumors, calcium and metabolic bone disorders, growth abnormalities, and the integration of advanced diabetes technologies into patient care. I maintain an active academic and research portfolio with publications in thyroid disease, pituitary pathology, diabetes, and hyperandrogenism. My particular strengths lie in thyroid oncology, pituitary disorders, diabetes, and the application of evidence‑based endocrine practice. Across all roles, I remain committed to delivering high‑quality, patient‑centered endocrine care while contributing to the advancement of the field through research, mentorship, and clinical excellence.